BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX)

Q: What does CUSIP 09075V102 represent in this 13F holders report?

CUSIP 09075V102 is the security identifier for BNTX - BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) used to aggregate holder disclosures.

Q: How many institutions held BNTX - BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) in Q2 2025?

255 institutional investors reported BNTX - BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) for Q2 2025. Use the holders table for investor-level position and value details.

CUSIP: 09075V102

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class: Equity / Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares)
Shares outstanding: 239,647,920
Total 13F shares: 53,756,637
Share change: +1,917,307
Total reported value: $5,723,405,583
Put/Call ratio: 125%
Price per share: $106.47
Number of holders: 255
Value change: +$241,986,249
Number of buys: 113
Number of sells: 132

Quarterly Holders Quick Answers

What is CUSIP 09075V102?
CUSIP 09075V102 identifies BNTX - BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2025
Previous quarter: Q1 2025

Recent filing periods for CUSIP 09075V102:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of BNTX - BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Medine GmbH	13D/G	Prof. Ugur Sahin, M.D.	18%	42,178,034	$4,386,515,536	$0	31 Mar 2025	13D/G
BAILLIE GIFFORD & CO	13F	Company	3.4%	8,159,682	$743,020,643	—	31 Mar 2025	13F
FMR LLC	13F	Company	3%	7,283,411	$663,227,406	—	31 Mar 2025	13F
Se Flossbach von Storch	13F	Individual	1.8%	4,259,631	$387,881,999	—	31 Mar 2025	13F
PRIMECAP MANAGEMENT CO/CA/	13F	Company	1.7%	4,046,425	$368,467,461	—	31 Mar 2025	13F
PFIZER INC	13F	Company	1.5%	3,658,361	$333,130,353	—	31 Mar 2025	13F
Temasek Holdings (Private) Ltd	13F	Company	0.75%	1,807,232	$164,566,545	—	31 Mar 2025	13F
BlackRock, Inc.	13F	Company	0.7%	1,665,939	$151,700,422	—	31 Mar 2025	13F
Capital International Investors	13F	Company	0.6%	1,428,441	$130,073,837	—	31 Mar 2025	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0.5%	1,195,470	$108,859,498	—	31 Mar 2025	13F
VIKING GLOBAL INVESTORS LP	13F	Company	0.37%	879,972	$80,130,250	—	31 Mar 2025	13F
MORGAN STANLEY	13F	Company	0.3%	713,606	$64,981,074	—	31 Mar 2025	13F
Bank of New York Mellon Corp	13F	Company	0.29%	698,368	$63,593,335	—	31 Mar 2025	13F
S.c.a. Candriam	13F	Individual	0.28%	670,955	$61,097,534	—	31 Mar 2025	13F
GILDER GAGNON HOWE & CO LLC	13F	Company	0.27%	649,284	$59,123,801	—	31 Mar 2025	13F
Invesco Ltd.	13F	Company	0.27%	645,142	$58,746,630	—	31 Mar 2025	13F
Capital International, Inc./CA/	13F	Company	0.27%	638,099	$58,105,295	—	31 Mar 2025	13F
ALTRINSIC GLOBAL ADVISORS LLC	13F	Company	0.26%	620,766	$56,526,952	—	31 Mar 2025	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.23%	544,970	$49,624,968	—	31 Mar 2025	13F
UBS Group AG	13F	Company	0.21%	493,931	$44,977,357	—	31 Mar 2025	13F
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main	13F	Company	0.2%	478,257	$43,542,877	—	31 Mar 2025	13F
FRANKLIN RESOURCES INC	13F	Company	0.18%	425,442	$38,740,838	—	31 Mar 2025	13F
Deutsche Girozentrale DekaBank	13F	Individual	0.17%	411,897	$36,620,000	—	31 Mar 2025	13F
Aberdeen Group plc	13F	Company	0.16%	385,668	$35,118,928	—	31 Mar 2025	13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC	13F	Company	0.16%	382,979	$34,874,068	—	31 Mar 2025	13F
Squarepoint Ops LLC	13F	Company	0.15%	347,727	$31,664,021	—	31 Mar 2025	13F
FIRST TRUST ADVISORS LP	13F	Company	0.13%	316,935	$28,860,101	—	31 Mar 2025	13F
LBP AM SA	13F	Company	0.13%	305,221	$27,793,425	—	31 Mar 2025	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.12%	293,776	$26,751,242	—	31 Mar 2025	13F
DEUTSCHE BANK AG\	13F	Company	0.12%	289,788	$26,388,096	—	31 Mar 2025	13F
Amundi	13F	Individual	0.11%	268,337	$24,689,688	—	31 Mar 2025	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.11%	270,211	$24,605,413	—	31 Mar 2025	13F
TANG CAPITAL MANAGEMENT LLC	13F	Company	0.11%	270,000	$24,586,200	—	31 Mar 2025	13F
CITIGROUP INC	13F	Company	0.11%	261,984	$23,856,263	—	31 Mar 2025	13F
MARSHALL WACE, LLP	13F	Company	0.11%	255,890	$23,293,591	—	31 Mar 2025	13F
Legal & General Group Plc	13F	Company	0.11%	253,460	$23,057,595	—	31 Mar 2025	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.1%	243,468	$22,170,196	—	31 Mar 2025	13F
CITADEL ADVISORS LLC	13F	Company	0.09%	221,190	$20,141,562	—	31 Mar 2025	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.09%	218,422	$19,889,508	—	31 Mar 2025	13F
Asset Managment Groupama	13F	Individual	0.08%	196,544	$18,661,853	—	31 Mar 2025	13F
Logos Global Management LP	13F	Company	0.08%	200,000	$18,212,000	—	31 Mar 2025	13F
Quinn Opportunity Partners LLC	13F	Company	0.08%	197,946	$18,024,963	—	31 Mar 2025	13F
MACQUARIE GROUP LTD	13F	Company	0.08%	190,252	$17,174,879	—	31 Mar 2025	13F
Gestion Carmignac	13F	Individual	0.08%	185,877	$17,004,672	—	31 Mar 2025	13F
Mitsubishi UFJ Trust & Banking Corp	13F	Company	0.07%	178,997	$16,299,467	—	31 Mar 2025	13F
CANADA PENSION PLAN INVESTMENT BOARD	13F	Company	0.07%	177,839	$16,194,019	—	31 Mar 2025	13F
Hudson Bay Capital Management LP	13F	Company	0.07%	165,000	$15,024,900	—	31 Mar 2025	13F
Long Focus Capital Management, LLC	13F	Company	0.07%	159,000	$14,478,540	—	31 Mar 2025	13F
STATE STREET CORP	13F	Company	0.06%	152,911	$13,924,076	—	31 Mar 2025	13F
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC	13F	Company	0.06%	145,687	$13,266,258	—	31 Mar 2025	13F

Institutional Holders of BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) as of Q2 2025

As of 30 Jun 2025, BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) was held by 255 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 53,756,637 shares. The largest 10 holders included FMR LLC, BAILLIE GIFFORD & CO, FLOSSBACH VON STORCH SE, PRIMECAP MANAGEMENT CO/CA/, Pfizer Inc, T. Rowe Price Investment Management, Inc., Temasek Holdings (Private) Ltd, BlackRock, Inc., BNP PARIBAS FINANCIAL MARKETS, and Capital International Investors. This page lists 256 institutional shareholders reporting positions in this security for the Q2 2025 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders

276

Q2 2025 holders

255

Holder diff

-21

Investor	Q1 2025 Shares	Q2 2025 Shares	Share Diff	Share Chg %	Q1 2025 Value $	Q2 2025 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.